LASIK advancement: Alcon gets FDA approval for LADARVision system

Article

Hunenberg, Switzerland-The FDA has approved Alcon Inc.'s LADARVision System for customized wavefront-guided laser eye surgery in the treatment of myopia.

Recent Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
What keeps you up at night in ophthalmology: Part II
Chris Adams, Diopter Corp CEO
Ramin Valian, of Allergan, discusses pharmaceuticals in the glaucoma industry at Glaucoma 360
© 2024 MJH Life Sciences

All rights reserved.